How are TNDM strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the TNDM strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 72.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$180.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a TNDM strangle?

The breakeven for the TNDM strangle priced on this page is roughly $10.20 and $14.80 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TNDM market-implied 1-standard-deviation expected move is approximately 20.87%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current TNDM implied volatility affect this strangle?

TNDM ATM IV is at 72.80% with IV rank near 19.86%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

TNDM Strangle Strategy

TNDM (Tandem Diabetes Care, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008.

TNDM (Tandem Diabetes Care, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $966.9M, a beta of 1.64 versus the broader market, a 52-week range of 9.98-29.65, average daily share volume of 2.4M, a public-listing history dating back to 2013, approximately 3K full-time employees. These structural characteristics shape how TNDM stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.64 indicates TNDM has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a strangle on TNDM?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current TNDM snapshot

As of May 15, 2026, spot at $12.59, ATM IV 72.80%, IV rank 19.86%, expected move 20.87%. The strangle on TNDM below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this strangle structure on TNDM specifically: TNDM IV at 72.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a TNDM strangle, with a market-implied 1-standard-deviation move of approximately 20.87% (roughly $2.63 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TNDM expiries trade a higher absolute premium for lower per-day decay. Position sizing on TNDM should anchor to the underlying notional of $12.59 per share and to the trader's directional view on TNDM stock.

TNDM strangle setup

The TNDM strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TNDM near $12.59, the first option leg uses a $13.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TNDM chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TNDM shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$13.00	$1.00
Buy 1	Put	$12.00	$0.80

TNDM strangle risk and reward

Net Premium / Debit: -$180.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$180.00
Breakeven(s): $10.20, $14.80
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

TNDM strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on TNDM. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.9%	+$1,019.00
$2.79	-77.8%	+$740.74
$5.58	-55.7%	+$462.48
$8.36	-33.6%	+$184.22
$11.14	-11.5%	-$94.05
$13.92	+10.6%	-$87.69
$16.71	+32.7%	+$190.57
$19.49	+54.8%	+$468.83
$22.27	+76.9%	+$747.09
$25.05	+99.0%	+$1,025.35

When traders use strangle on TNDM

Strangles on TNDM are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the TNDM chain.

TNDM thesis for this strangle

The market-implied 1-standard-deviation range for TNDM extends from approximately $9.96 on the downside to $15.22 on the upside. A TNDM long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current TNDM IV rank near 19.86% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on TNDM at 72.80%. As a Healthcare name, TNDM options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TNDM-specific events.

TNDM strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TNDM positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TNDM alongside the broader basket even when TNDM-specific fundamentals are unchanged. Always rebuild the position from current TNDM chain quotes before placing a trade.

Frequently asked questions

What is a strangle on TNDM?: A strangle on TNDM is the strangle strategy applied to TNDM (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With TNDM stock trading near $12.59, the strikes shown on this page are snapped to the nearest listed TNDM chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are TNDM strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the TNDM strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 72.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$180.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a TNDM strangle?: The breakeven for the TNDM strangle priced on this page is roughly $10.20 and $14.80 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TNDM market-implied 1-standard-deviation expected move is approximately 20.87%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on TNDM?: Strangles on TNDM are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the TNDM chain.
How does current TNDM implied volatility affect this strangle?: TNDM ATM IV is at 72.80% with IV rank near 19.86%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.